Stock Scorer

LifeStance Health Group, Inc. (LFST)

LifeStance Health Group, Inc. reported revenue of 435.4M USD for the quarter ending 30 June 2026, up 26.1% from 345.3M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 435.4M +26.1%
Operating Income Q2 '26 · ending 30 June 2026 30.7M —
Net Income Q2 '26 · ending 30 June 2026 23.6M —
Operating Cash Flow Q2 '26 · ending 30 June 2026 99.9M +55.2%
Free Cash Flow Q2 '26 · ending 30 June 2026 87.9M +55.2%
Shares Outstanding Q2 '26 · ending 30 June 2026 387.3M -0.9%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 1.4B24.1M9.7M110M
20242024-12-31 1.3B-31.6M-57.4M85.7M
20232023-12-31 1.1B-189.1M-186.3M-57.4M
20222022-12-31 859.5M-210.2M-215.6M-26.5M
20212021-12-31 667.5M-286.4M-307.2M-85.1M
20192019-12-31 212.5M15.2M5.7M2.7M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30435.4M
Q1 '262026-03-31403.5M
Q4 '252025-12-31382.2M
Q3 '252025-09-30363.8M
Q2 '252025-06-30345.3M
Q1 '252025-03-31333M
Q4 '242024-12-31325.5M
Q3 '242024-09-30312.7M
Q2 '242024-06-30312.3M
Q1 '242024-03-31300.4M
Q4 '232023-12-31280.6M
Q3 '232023-09-30262.9M
Q2 '232023-06-30259.6M
Q1 '232023-03-31252.6M
Q4 '222022-12-31229.4M
Q3 '222022-09-30217.6M
Q2 '222022-06-30209.5M
Q1 '222022-03-31203.1M
Q4 '212021-12-31190M
Q3 '212021-09-30173.8M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-3030.7M
Q1 '262026-03-3122.3M
Q4 '252025-12-3118.1M
Q3 '252025-09-307.4M
Q2 '252025-06-30-3M
Q1 '252025-03-311.6M
Q4 '242024-12-311.1M
Q3 '242024-09-3047K
Q2 '242024-06-30-15.9M
Q1 '242024-03-31-16.8M
Q4 '232023-12-31-32.3M
Q3 '232023-09-30-74.4M
Q2 '232023-06-30-48.4M
Q1 '232023-03-31-34.1M
Q4 '222022-12-31-46M
Q3 '222022-09-30-38.8M
Q2 '222022-06-30-60.5M
Q1 '222022-03-31-64.9M
Q4 '212021-12-31-113.8M
Q3 '212021-09-30-124.7M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-3023.6M
Q1 '262026-03-3114.2M
Q4 '252025-12-3111.7M
Q3 '252025-09-301.1M
Q2 '252025-06-30-3.8M
Q1 '252025-03-31709K
Q4 '242024-12-31-7.1M
Q3 '242024-09-30709K
Q2 '242024-06-30-23.3M
Q1 '242024-03-31-21.1M
Q4 '232023-12-31-45M
Q3 '232023-09-30-61.6M
Q2 '232023-06-30-45.5M
Q1 '232023-03-31-34.2M
Q4 '222022-12-31-46.7M
Q3 '222022-09-30-37.9M
Q2 '222022-06-30-68.7M
Q1 '222022-03-31-62.3M
Q4 '212021-12-31-108M
Q3 '212021-09-30-120.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3099.9M
Q1 '262026-03-3133.1M
Q4 '252025-12-3157.6M
Q3 '252025-09-3027.3M
Q2 '252025-06-3064.4M
Q1 '252025-03-31-3.1M
Q4 '242024-12-3162.3M
Q3 '242024-09-3022.7M
Q2 '242024-06-3044.1M
Q1 '242024-03-31-21.8M
Q4 '232023-12-3116.8M
Q3 '232023-09-30-25.4M
Q2 '232023-06-30-434K
Q1 '232023-03-31-7.9M
Q4 '222022-12-3135.9M
Q3 '222022-09-305.7M
Q2 '222022-06-307.8M
Q1 '222022-03-313.3M
Q4 '212021-12-3130.6M
Q3 '212021-09-30-14.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3087.9M
Q1 '262026-03-3122.3M
Q4 '252025-12-3146.6M
Q3 '252025-09-3017M
Q2 '252025-06-3056.6M
Q1 '252025-03-31-10.3M
Q4 '242024-12-3156M
Q3 '242024-09-3017.7M
Q2 '242024-06-3039M
Q1 '242024-03-31-26.9M
Q4 '232023-12-315.4M
Q3 '232023-09-30-35.2M
Q2 '232023-06-30-12M
Q1 '232023-03-31-15.6M
Q4 '222022-12-3125.5M
Q3 '222022-09-30-9.4M
Q2 '222022-06-30-18M
Q1 '222022-03-31-24.6M
Q4 '212021-12-31-8M
Q3 '212021-09-30-38.2M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30387.3M
Q1 '262026-03-31395.1M
Q3 '252025-09-30388.9M
Q2 '252025-06-30386.7M
Q1 '252025-03-31390.7M
Q3 '242024-09-30380.4M
Q2 '242024-06-30379.4M
Q1 '242024-03-31376.3M
Q3 '232023-09-30372.5M
Q2 '232023-06-30363.2M
Q1 '232023-03-31360.9M
Q3 '222022-09-30357.5K
Q2 '222022-06-30353.7K
Q1 '222022-03-31350.8K
Q3 '212021-09-30343.4K
Q2 '212021-06-30313.5K